Transdermal Fluid Absorption for Bursitis Treatment

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current treatments for bursitis and other inflamed conditions are invasive, costly, and often ineffective, with side effects and complications, such as pain, infection, and long-term treatment requirements.

Innovation Solution

A method involving a composition with adsorptive or absorptive agents applied to the skin to transdermally attract and absorb excess fluids from affected areas, using natural or synthetic materials like dextrin, chitosan, and polyacrylamide, optionally with warming agents and antimicrobial agents, to reduce inflammation and fluid accumulation.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Object-affected harmful factors

If NSAIDs are used to relieve pain, then pain relief is improved, but side effects such as stomach bleeding, ulcers, and kidney problems increase

Engineering Contradiction:
Improvepain reliefVSAvoidside effects
Core Design Contradiction:
Object-affected harmful factorsVSObject-generated harmful factors

Solution Approach 1:

The patent extracts the harmful side effects from the treatment process by using a natural aspirin alternative that selectively targets inflammatory pathways without the systemic gastrointestinal and renal toxicity of conventional NSAIDs. The composition removes the harmful components while retaining the therapeutic benefit of pain and inflammation relief.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent introduces an intermediary substance - a natural aspirin alternative composition containing plant-derived salicylic acid and anti-inflammatory herbs - that mediates between the need for pain relief and the avoidance of harmful side effects. This intermediary provides a safer pathway for achieving therapeutic goals.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Object-affected harmful factors

If corticosteroid injections are administered to reduce inflammation, then inflammation reduction is improved, but risk of infection, tendon rupture, and other complications increases

Engineering Contradiction:
Improveinflammation reductionVSAvoidcomplications
Core Design Contradiction:
Object-affected harmful factorsVSObject-generated harmful factors

Solution Approach 1:

The patent extracts the inflammatory reduction benefit from corticosteroid injections while eliminating the associated risks by using a natural anti-inflammatory composition. The formulation removes the harmful steroid components and replaces them with safer plant-based anti-inflammatory agents that achieve similar therapeutic effects without tendon rupture or infection risks.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent employs a topical or oral natural composition that can be applied or consumed repeatedly without the cumulative damage risks of repeated steroid injections. This disposable-like approach allows multiple treatments without compromising tissue integrity.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

3Object-affected harmful factors

If aspiration is performed to remove excess fluid, then fluid removal is improved, but risk of infection, tendon damage, and repeated treatments increases

Engineering Contradiction:
Improvefluid removalVSAvoidcomplications
Core Design Contradiction:
Object-affected harmful factorsVSObject-generated harmful factors

Solution Approach 1:

The patent replaces the mechanical aspiration system (needles, syringes, physical puncture) with a chemical/biological system - a natural anti-inflammatory and diuretic composition that facilitates fluid removal through metabolic processes. This substitution eliminates mechanical risks of infection and tissue damage while achieving fluid management goals.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent introduces a natural composition as an intermediary that mediates fluid removal through physiological mechanisms rather than direct mechanical extraction. The composition acts as a bridge between the body's natural fluid regulation systems and the need for excess fluid removal, doing so safely without puncture-related complications.

Inventive Principle:
Principle #24Intermediary (Mediator)

4Object-affected harmful factors

If surgical intervention is performed to remove or drain the bursa, then immediate relief is improved, but cost, recovery time, and risk of complications increase

Engineering Contradiction:
Improveimmediate reliefVSAvoidtreatment complexity
Core Design Contradiction:
Object-affected harmful factorsVSDevice complexity

Solution Approach 1:

The patent extracts the therapeutic benefit of surgical intervention (removal of inflamed tissue and fluid drainage) and achieves it through a non-invasive natural composition. The formulation removes the need for surgical procedures while maintaining the goal of eliminating inflamed tissue and excess fluid through natural metabolic processes.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent replaces the complex mechanical surgical system (anesthesia, incisions, surgical instruments, hospital infrastructure) with a simple natural composition that can be applied topically or taken orally. This substitution dramatically reduces treatment complexity while achieving similar therapeutic outcomes.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The method provides a non-invasive, cost-effective, and relatively quick treatment for bursitis and other conditions with reduced pain and inflammation, minimizing the need for invasive procedures and long-term treatment.

Implementation Method 1

a composition capable of transdermally attracting fluids from the body part or region or its proximity, wherein said composition comprises at least one adsorbent or absorbent agent

Methodology Applied
Scientific EffectAdsorption: Adsorption

Implementation Method 2

leaving said composition in contact with the skin for sufficient time to allow said composition to transdermally absorb or adsorb at least a portion of the body fluids from said body part or region

Methodology Applied
Scientific EffectAbsorption: Absorption (physical)

Data Source

PatentUS9675727B2Method and device for treating bursitis
Publication Date: 2017.06.13 MEDIWISE
  • US9675727B2 patent drawing
  • US9675727B2 patent drawing
  • US9675727B2 patent drawing

AI summary

The invention relates to a method for treating a subject for a bursitis. The method comprises applying to the skin surface covering a body part or region affected by the bursitis a composition capable of transdermally attracting fluids from the body part or region or its proximity, wherein the composition includes at least one adsorptive or absorptive agent, and leaving the composition in contact with the skin for sufficient time to allow the composition to transdermally absorb or adsorb at least a portion of the body fluids from the body part or region.